Investigación

Farmacología molecular y terapias experimentales

Buscador de publicaciones

Publicaciones

  • Boces-Pascual C, Mata A, Martín-Satué M, Boix L, Gironella M, Pastor-Anglada M and Perez-Torras S.

    OncomiRs miR-106a and miR-17 negatively regulate the nucleoside-derived drug transporter hCNT1.

    CELLULAR AND MOLECULAR LIFE SCIENCES . 78(23): 7505-7518.

    [doi:10.1007/s00018-021-03959-8]

  • Pena-Rodríguez E, Mata A, Laura García Vega, Pérez-Torras S and Fernández-Campos F.

    The Physicochemical, Biopharmaceutical, and In Vitro Efficacy Properties of Freeze-Dried Dexamethasone-Loaded Lipomers.

    Pharmaceutics . 13(8): 1322.

    [doi:10.3390/pharmaceutics13081322]

  • Pena-Rodríguez E, Lajarin-Reinares M, Mata-Ventosa A, Perez-Torras S and Fernández-Campos F.

    Dexamethasone-Loaded Lipomers: Development, Characterization, and Skin Biodistribution Studies.

    Pharmaceutics . 13(4): 533.

    [doi:10.3390/pharmaceutics13040533]

  • Guillén-Gómez E, Silva I, Serra N, Caballero F, Leal J, Breda A, San Martín R, Pastor-Anglada M, Ballarín JA, Guirado L and Díaz-Encarnación MM.

    From Inflammation to the Onset of Fibrosis through A(2A) Receptors in Kidneys from Deceased Donors.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 21(22): .

    [doi:10.3390/ijms21228826]

  • Jaramillo AC, Hubeek I, Broekhuizen R, Pastor-Anglada M, Kaspers GJL, Jansen G, Cloos J and Peters GJ.

    Expression of the nucleoside transporters hENT1 (SLC29) and hCNT1 (SLC28) in pediatric acute myeloid leukemia.

    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS . 39(10-12): 1379-1388. Nº de citas: 4

    [doi:10.1080/15257770.2020.1746803]

  • Perello C, Català-Temprano A, Caviedes L, Vega-García N, Camós-Guijosa M, Perez-Torras S and Pastor-Anglada M.

    FMS-like tyrosine kinase 3 (FLT3) modulates key enzymes of nucleotide metabolism implicated in cytarabine responsiveness in pediatric acute leukemia.

    PHARMACOLOGICAL RESEARCH . 151: 104556-104556. Nº de citas: 3

    [doi:10.1016/j.phrs.2019.104556]

  • Vaskó B, Juhász V, Tóth B, Kurunczi A, Fekete Z, Zolnerciks JK, Kis E, Magnan R, Bidon-Chanal Badia A, Pastor-Anglada M, Hazai E, Bikadi Z, Fülöp F and Krajcsi P.

    Inhibitor selectivity of CNTs and ENTs.

    Xenobiotica . 49(7): 840-851. Nº de citas: 1

    [doi:10.1080/00498254.2018.1501832]

  • Perez-Torras S, Mata-Ventosa A, Drögemöller B, Tarailo-Graovac M, Meijer J, Meinsma R, van Cruchten AG, Kulik W, Viel-Oliva A, Bidon-Chanal A, Ross CJ, Wassermann WW, van Karnebeek CDM, Pastor-Anglada M and van Kuilenburg ABP.

    Deficiency of perforin and hCNT1, a novel inborn error of pyrimidine metabolism, associated with a rapidly developing lethal phenotype due to multi-organ failure.

    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE . 1865(6): 1182-1191. Nº de citas: 3

    [doi:10.1016/j.bbadis.2019.01.013]

  • Grañe-Boladeras N, Williams D, Tarmakova Z, Stevanovic K, Villani LA, Mehrabi P, Siu KWM, Pastor-Anglada M and Coe IR.

    Oligomerization of equilibrative nucleoside transporters: a novel regulatory and functional mechanism involving PKC and PP1.

    FASEB JOURNAL . 33(3): 3841-3850. Nº de citas: 6

    [doi:10.1096/fj.201800440RR]

  • Pastor-Anglada M, Urtasun N and Perez-Torras S.

    Intestinal Nucleoside Transporters: Function, Expression, and Regulation.

    COMPREHENSIVE PHYSIOLOGY . 8(3): 1003-1017. Nº de citas: 25

    [doi:10.1002/cphy.c170039]